Systemic Mastocytosis, Version 3.2024: Featured Updates to the NCCN Guidelines

被引：0

作者：

Gotlib, Jason ^{[1
]}

Gerds, Aaron T. ^{[2
,3
]}

Abdelmessieh, Peter ^{[4
]}

Ali, Haris ^{[5
]}

Castells, Mariana ^{[6
]}

Dunbar, Andrew ^{[7
]}

Revell, Ruth Fein ^{[8
]}

George, Tracy I. ^{[9
]}

Green, Steven ^{[10
]}

Gundabolu, Krishna ^{[11
]}

Hexner, Elizabeth ^{[12
]}

Jain, Tania ^{[13
]}

Jamieson, Catriona ^{[14
]}

Kaesberg, Paul R. ^{[15
]}

Kuykendall, Andrew T. ^{[16
]}

Madanat, Yazan ^{[17
]}

Manchanda, Naveen ^{[18
]}

Masarova, Lucia ^{[19
]}

May, Jori ^{[20
]}

McMahon, Brandon ^{[21
]}

Mohan, Sanjay R. ^{[22
]}

Nadiminti, Kalyan V. ^{[23
]}

Oh, Stephen ^{[24
,25
]}

Palmer, Jeanne ^{[26
]}

Patel, Ami ^{[9
]}

Patel, Anand A. ^{[27
]}

Podoltsev, Nikolai ^{[28
]}

Rein, Lindsay ^{[29
]}

Salit, Rachel ^{[30
]}

Talpaz, Moshe ^{[31
]}

Wadleigh, Martha ^{[6
]}

Wall, Sarah ^{[32
,33
]}

Bergman, Mary Anne ^{[34
]}

Hochstetler, Cindy ^{[34
]}

机构：

[1] Stanford Canc Inst, Stanford, CA 94305 USA

[2] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[3] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA

[4] Fox Chase Canc Ctr, Philadelphia, PA USA

[5] City Hope Natl Med Ctr, Duarte, CA USA

[6] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[7] Mem Sloan Kettering Canc Ctr, New York, NY USA

[8] Patient Advocate, Gray, ME USA

[9] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[10] Roswell Park Comprehens Canc Ctr, Biostat, Buffalo, NY USA

[11] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[12] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA

[13] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[14] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA

[15] Univ Calif Davis, Comprehens Canc Ctr, Davis, CA USA

[16] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[17] UT Southwestern, Simmons Comprehens Canc Ctr, Dallas, TX USA

[18] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN USA

[19] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[20] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA

[21] Univ Colorado, Ctr Canc, Denver, CO USA

[22] Vanderbilt Ingram Canc Ctr, Memphis, TN USA

[23] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA

[24] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[25] Washington Univ, Sch Med, Washington, DC USA

[26] Mayo Clin, Comprehens Canc Ctr, Rochester, NY USA

[27] UChicago Med, Comprehens Canc Ctr, Maywood, IL USA

[28] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[29] Duke Canc Inst, Durham, NC USA

[30] Fred Hutchinson Canc Ctr, Seattle, WA USA

[31] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA

[32] Ohio State Univ, James Canc Hosp, Comprehens Canc Ctr, Columbus, OH USA

[33] Solove Res Inst, Columbus, OH USA

[34] Natl Comprehens Canc Network, Plymouth Meeting, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2024年 / 22卷 / 2D期

关键词：

INTERFERON-ALPHA; PHASE-II; FIP1L1-PDGFRA FUSION; CELL TRANSPLANTATION; IMATINIB MESYLATE; WILD-TYPE; MIDOSTAURIN; EFFICACY; THERAPY; SAFETY;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Mastocytosis is a heterogeneous group of disorders comprising cutaneous mastocytosis, systemic mastocytosis, and mast cell sarcoma. It is associated with a variety of symptoms related to the release of mast cell mediators and mast cell tissue in filtration. Referral to specialized centers with expertise in the management of mastocytosis and multidisciplinary collaboration with subspecialists (eg, allergists for the management of anaphylaxis and drug hypersensitivities, anesthesiologists for invasive procedures or surgery, high -risk obstetrician for pregnancy) is recommended. The NCCN Guidelines for Systemic Mastocytosis provide evidence- and consensus -based recommendations for the diagnosis and comprehensive care of patients with systemic mastocytosis. The multidisciplinary panel of experts convenes at least once a year to review requested changes to the guidelines from both internal and external entities as well as to discuss data on existing and new therapies. These NCCN Guidelines Insights focus on some of the recent updates to the guidelines.

引用

页数：9

共 42 条

[1] A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib [J].

Akin, C ;

Fumo, G ;

Yavuz, AS ;

Lipsky, PE ;

Neckers, L ;

Metcalfe, DD .

BLOOD, 2004, 103 (08) :3222-3225

[2] Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit [J].

Akin, C ;

Brockow, K ;

D'Ambrosio, C ;

Kirshenbaum, AS ;

Ma, YS ;

Longley, BJ ;

Metcalfe, DD .

EXPERIMENTAL HEMATOLOGY, 2003, 31 (08) :686-692

[3] Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature [J].

Alvarez-Twose, Ivan ;

Matito, Almudena ;

Mario Morgado, Jose ;

Sanchez-Munoz, Laura ;

Jara-Acevedo, Maria ;

Garcia-Montero, Andres ;

Mayado, Andrea ;

Caldas, Carolina ;

Teodosio, Cristina ;

Ignacio Munoz-Gonzalez, Javier ;

Mollejo, Manuela ;

Escribano, Luis ;

Orfao, Alberto .

ONCOTARGET, 2017, 8 (40) :68950-68963

[4] International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data [J].

Arber, Daniel A. ;

Orazi, Attilio ;

Hasserjian, Robert P. ;

Borowitz, Michael J. ;

Calvo, Katherine R. ;

Kvasnicka, Hans-Michael ;

Wang, Sa A. ;

Bagg, Adam ;

Barbui, Tiziano ;

Branford, Susan ;

Bueso-Ramos, Carlos E. ;

Cortes, Jorge E. ;

Dal Cin, Paola ;

DiNardo, Courtney D. ;

Dombret, Herve ;

Duncavage, Eric J. ;

Ebert, Benjamin L. ;

Estey, Elihu H. ;

Facchetti, Fabio ;

Foucar, Kathryn ;

Gangat, Naseema ;

Gianelli, Umberto ;

Godley, Lucy A. ;

Gokbuget, Nicola ;

Gotlib, Jason ;

Hellstrom-Lindberg, Eva ;

Hobbs, Gabriela S. ;

Hoffman, Ronald ;

Jabbour, Elias J. ;

Kiladjian, Jean-Jacques ;

Larson, Richard A. ;

Le Beau, Michelle M. ;

Loh, Mignon L. -C. ;

Lowenberg, Bob ;

Macintyre, Elizabeth ;

Malcovati, Luca ;

Mullighan, Charles G. ;

Niemeyer, Charlotte ;

Odenike, Olatoyosi M. ;

Ogawa, Seishi ;

Orfao, Alberto ;

Papaemmanuil, Elli ;

Passamonti, Francesco ;

Porkka, Kimmo ;

Pui, Ching-Hon ;

Radich, Jerald P. ;

Reiter, Andreas ;

Rozman, Maria ;

Rudelius, Martina ;

Savona, Michael R. .

BLOOD, 2022, 140 (11) :1200-1228

[5] Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis [J].

Barete, Stephane ;

Lortholary, Olivier ;

Damaj, Gandhi ;

Hirsch, Isabelle ;

Chandesris, Marie Olivia ;

Elie, Caroline ;

Hamidou, Mohamed ;

Durieu, Isabelle ;

Suarez, Felipe ;

Grosbois, Bernard ;

Limal, Nicolas ;

Gyan, Emmanuel ;

Larroche, Claire ;

Guillet, Gerard ;

Kahn, Jean Emmanuel ;

Casassus, Philippe ;

Amazzough, Karima ;

Coignard-Biehler, Helene ;

Georgin-Lavialle, Sophie ;

Lhermitte, Ludovic ;

Fraitag, Sylvie ;

Canioni, Danielle ;

Dubreuil, Patrice ;

Hermine, Olivier .

BLOOD, 2015, 126 (08) :1009-1016

[6] Treatment of adult systemic mastocytosis with interferon-α:: results of a multicentre phase II trial on 20 patients [J].

Casassus, P ;

Caillat-Vigneron, N ;

Martin, A ;

Simon, J ;

Gallais, V ;

Beaudry, P ;

Eclache, V ;

Laroche, L ;

Lortholary, P ;

Raphaël, M ;

Guillevin, L ;

Lortholary, O .

BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (04) :1090-1097

[7] Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management [J].

Castells, Mariana ;

Butterfield, Joseph .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (04) :1097-1106

[8] Midostaurin in Advanced Systemic Mastocytosis [J].

Chandesris, Marie-Olivia ;

Damaj, Gandhi ;

Canioni, Danielle ;

Brouzes, Chantal ;

Lhermitte, Ludovic ;

Hanssens, Katia ;

Frenzel, Laurent ;

Cherquaoui, Zoubair ;

Durieu, Isabelle ;

Durupt, Stephane ;

Gyan, Emmanuel ;

Beyne-Rauzy, Odille ;

Launay, David ;

Faure, Cyril ;

Hamidou, Mohamed ;

Besnard, Sophie ;

Diouf, Momar ;

Schiffmann, Aurelie ;

Niault, Mathilde ;

Jeandel, Pierre-Yves ;

Ranta, Dana ;

Gressin, Remi ;

Chantepie, Sylvain ;

Barete, Stephane ;

Dubreuil, Patrice ;

Bourget, Philippe ;

Lortholary, Olivier ;

Hermine, Olivier .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (26) :2605-2607

[9] Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial [J].

DeAngelo, D. J. ;

George, T. I. ;

Linder, A. ;

Langford, C. ;

Perkins, C. ;

Ma, J. ;

Westervelt, P. ;

Merker, J. D. ;

Berube, C. ;

Coutre, S. ;

Liedtke, M. ;

Medeiros, B. ;

Sternberg, D. ;

Dutreix, C. ;

Ruffie, P-A ;

Corless, C. ;

Graubert, T. J. ;

Gotlib, J. .

LEUKEMIA, 2018, 32 (02) :470-478

[10] Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial [J].

DeAngelo, Daniel J. ;

Radia, Deepti H. ;

George, Tracy, I ;

Robinson, William A. ;

Quiery, Albert T. ;

Drummond, Mark W. ;

Bose, Prithviraj ;

Hexner, Elizabeth O. ;

Winton, Elliott F. ;

Horny, Hans-Peter ;

Tugnait, Meera ;

Schmidt-Kittler, Oleg ;

Evans, Erica K. ;

Lin, Hui-Min ;

Mar, Brenton G. ;

Verstovsek, Srdan ;

Deininger, Michael W. ;

Gotlib, Jason .

NATURE MEDICINE, 2021, 27 (12) :2183-+

← 1 2 3 4 5 →